In Vitro Fertilization (IVF) Hormones Market Trends

  • Report ID: 65
  • Published Date: Sep 20, 2024
  • Report Format: PDF, PPT

In Vitro Fertilization (IVF) Hormones Market Trends

Growth Drivers

Growing Concern for the Rising Infertility Rate Among Individuals to Propel the Growth of the Market

According to the Centers for Disease Control and Prevention (CDC), PCOS is one of the most common causes of female infertility amongst the US women of reproductive age, affecting as many as 5 million individuals (6% to 12% of US women of reproductive age).

One of the major causes of infertility in women is due to the occurrence of polycystic ovary syndrome (PCOS), which is linked to being overweight or having a family history of type 2 diabetes or PCOS. Rising awareness for infertility treatment, owing to the increasing incidences of infertility, rising cases of PCOS, and the growing number of couples who defer childbearing, are some of the factors anticipated to drive the demand for the use of IVF hormones, and in turn, drive the in vitro fertilization (IVF) hormones market growth. Moreover, increasing advancements in the field of IVF treatments, along with the growing success rate of IVF treatments are some of the additional factors anticipated to drive the growth of the IVF hormones market in the coming years.

Challenges

High Cost of IVF Treatment and Health Risks Associated with the utilization of IVF Hormones to Hamper the Market Growth

With numerous advantages associated with in vitro fertilization treatment procedures, there also lies numerous disadvantages, that are anticipated to hamper the market growth. One of the primary challenges associated with the growth of the market is the high cost of IVF treatment, which directly affects the demand for IVF hormones. Alternatively, the concern for risk of multiple births upon the use of these hormones, along with the severe reactions caused by the fertility drugs, such as ovarian hyperstimulation syndrome, and the social barriers present in several under-developed and developing nations for adopting IVF treatment, are some of the major factors anticipated to lower the market growth in the coming years.

In Vitro Fertilization (IVF) Hormones Market: Key Insights

Base Year

2023

Forecast Year

2024–2036

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 65
  • Published Date: Sep 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing incidences of infertility worldwide, and the need amongst individuals to opt for IVF treatments, are some of the major factors driving the market growth.

The market is anticipated to grow with a moderate CAGR over the forecast period, i.e., 2021-2029.

The high cost of IVF treatment, health risks of taking IVF hormones are some of the major factors estimated to act as barriers to the growth of the market.

The major companies in the market are Merck KGaA (OTCMKTS: MKKGY), GENPHARM, Aquatic Group, BioVendor – Laboratorni medicina a.s., Biogenix Inc. Pvt. Ltd., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample